These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14988185)

  • 21. Management of familial hypercholesterolaemia in children and adolescents.
    Justo RN
    J Paediatr Child Health; 2012 Feb; 48(2):E53-8. PubMed ID: 22017319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Protective effects of pravastatin against atherosclerosis in children with familial hypercholesterolemia].
    Riesen WF
    Rev Med Suisse; 2005 Mar; 1(9):649. PubMed ID: 15813344
    [No Abstract]   [Full Text] [Related]  

  • 23. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting high-risk young patients for statin therapy.
    Gotto AM
    JAMA; 2004 Jul; 292(3):377-8. PubMed ID: 15265854
    [No Abstract]   [Full Text] [Related]  

  • 25. Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Ryu SK; Hutten BA; Vissers MN; Wiegman A; Kastelein JJ; Tsimikas S
    J Clin Lipidol; 2011; 5(1):50-6. PubMed ID: 21262507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin treatment in children with familial hypercholesterolemia: the younger, the better.
    Rodenburg J; Vissers MN; Wiegman A; van Trotsenburg AS; van der Graaf A; de Groot E; Wijburg FA; Kastelein JJ; Hutten BA
    Circulation; 2007 Aug; 116(6):664-8. PubMed ID: 17664376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies.
    Vergeer M; Zhou R; Bots ML; Duivenvoorden R; Koglin J; Akdim F; Mitchel YB; Huijgen R; Sapre A; de Groot E; Sijbrands EJ; Pasternak RC; Gagné C; Marais AD; Ballantyne CM; Isaacsohn JL; Stalenhoef AF; Kastelein JJ
    Circ Cardiovasc Imaging; 2010 Jul; 3(4):398-404. PubMed ID: 20494942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Children and statins.
    Tonstad S
    Acta Paediatr; 2003 Sep; 92(9):1001-2. PubMed ID: 14599058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial hypercholesterolemia: a decade of progress.
    Gidding SS
    J Pediatr; 2010 Feb; 156(2):176-7. PubMed ID: 20105635
    [No Abstract]   [Full Text] [Related]  

  • 30. [Worsening for using statin in carnitine palmityol transferase deficiency myopathy].
    Delgado-López F; Bautista-Lorite J; Villamil-Fernández F
    Rev Neurol; 2004 Jun 1-15; 38(11):1095. PubMed ID: 15202093
    [No Abstract]   [Full Text] [Related]  

  • 31. Familial hypercholesterolemia: current treatment options and patient selection for low-density lipoprotein apheresis.
    Hemphill LC
    J Clin Lipidol; 2010; 4(5):346-9. PubMed ID: 21122676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Only one of four patients with familial hypercholesterolaemia reach cholesterol treatment goals in primary prevention.
    Hollman G; Ek AC; Olsson AG
    J Intern Med; 2004 Aug; 256(2):176-7. PubMed ID: 15257732
    [No Abstract]   [Full Text] [Related]  

  • 34. The spectrum of statin therapy in hyperlipidemic children.
    Rodenburg J; Vissers MN; Trip MD; Wiegman A; Bakker HD; Kastelein JJ
    Semin Vasc Med; 2004 Nov; 4(4):313-20. PubMed ID: 15861313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterozygous familial hypercholesterolemia case study.
    Friedrich DA
    J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Statins--new mechanisms of action and new indications].
    Savolainen M
    Duodecim; 2000; 116(24):2833-8. PubMed ID: 12077889
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Ito MK; McGowan MP; Moriarty PM;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S38-45. PubMed ID: 21600528
    [No Abstract]   [Full Text] [Related]  

  • 38. [Genetic principles of food related problems--familial hypercholesterolaemia].
    Floré M; Robberecht N; Hermans H
    J Pharm Belg; 2012 Mar; (1):18-21. PubMed ID: 22536679
    [No Abstract]   [Full Text] [Related]  

  • 39. Dietary and drug treatment of severe hypercholesterolaemia.
    Lewis B
    Beitr Infusionsther; 1988; 23():39-46. PubMed ID: 2484781
    [No Abstract]   [Full Text] [Related]  

  • 40. Familial hypercholesterolaemia in Australia: new insights and developments.
    Hamilton-Craig IR; Watts GF
    Med J Aust; 2013 Feb; 198(2):72-3. PubMed ID: 23373481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.